IMO, RSH wanted the $15M funds ADR recently raised and they were aware of the very poor quarterly and that they will struggle to commerialise wheezo due to the niche small market. There was no correlation on how products could be integrated together and ADR's comment about wheezo was what I've been saying all along here but was slammed by the holders that I didn't know anything about Asthma because I didn't have real world experience (this comment came from someone who's son has Asthma and is apparently using wheezo but didn't know you can diagnosis Asthma attack.....sheeesh). I've done extensive research on this market.
Ann: Replacement Bidders Statement, page-23
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
-0.001(2.70%) |
Mkt cap ! $47.53M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.7¢ | 3.6¢ | $17.06K | 461.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 353796 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 118840 | 2 |
View Market Depth
| Last trade - 15.50pm 30/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |